FDA Approved: AMLODIPINE AND ATORVASTATIN — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves an original ANDA for AMLODIPINE AND ATORVASTATIN (Mylan Pharmaceuticals Inc.), a generic fixed-dose combination product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Artery Disease
• Hyperlipidemia
• Hypertension

Drugs mentioned

• Amlodipine and Atorvastatin (amlodipine besylate and atorvastatin calcium)

Snippet

ORIG AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)